A comparative study between two methods of delivery of chemotherapeutic agent in patients with bone and soft tissue sarcoma of lower extremity
- PMID: 37087416
- PMCID: PMC10122285
- DOI: 10.1186/s12891-023-06417-7
A comparative study between two methods of delivery of chemotherapeutic agent in patients with bone and soft tissue sarcoma of lower extremity
Abstract
Background: We aimed to compare the effects of peripherally inserted central catheters (PICC) and implantable venous access devices (TIVADs) in terms of complications and shoulder function in patients with malignant bone and soft tissue tumors of the lower extremities.
Methods: We analyzed 65 cases of TIVADs (chest wall) and 65 cases of PICC at the orthopedic department of the Fourth Hospital of Hebei Medical University between June 2019 and December 2021, which were diagnosed with malignant bone tumors or soft tissue tumors of the lower extremities (tumors had to be relatively sensitive to chemotherapy), received regular chemotherapy, with ≥ 14 cycles (42 weeks). The two groups were compared in terms of catheter indwelling time, catheter-related complications, Constant-Murley shoulder function score, and displacement of the position of the catheter end on the catheterization side.
Results: Compared to the PICC group, at six months after catheterization, the TIVADs group reported better outcomes for catheter indwelling time, catheter-related complications, and Constant-Murley score for the catheterization-side shoulder joint (p < 0.05). The TIVADs group also reported less displacement of the catheter end position after 180° abduction of the catheterization-side shoulder joint (p < 0.05).
Conclusions: Compared with PICC, TIVADs can prolong catheter indwelling time, reduce catheter-related complications, and maintain shoulder joint function, which makes it an ideal venous-access approach when providing chemotherapy to patients with malignant bone and soft tissue tumors of the lower extremities.
Keywords: Catheter complications; Chemotherapy; Shoulder function.
© 2023. The Author(s).
Conflict of interest statement
We have no conflicts of interest to disclose.
Figures
Similar articles
-
Peripherally inserted central catheter complications in neonates with upper versus lower extremity insertion sites.Adv Neonatal Care. 2013 Jun;13(3):198-204. doi: 10.1097/ANC.0b013e31827e1d01. Adv Neonatal Care. 2013. PMID: 23722492
-
Complications associated with the removal of totally implantable venous access devices (TIVADs): a retrospective analysis of 4,954 breast cancer patients in a single institution.BMC Surg. 2024 Oct 22;24(1):324. doi: 10.1186/s12893-024-02630-w. BMC Surg. 2024. PMID: 39438981 Free PMC article.
-
Which is Better for Patients with Breast Cancer: Totally Implanted Vascular Access Devices (TIVAD) or Peripherally Inserted Central Catheter (PICC)?World J Surg. 2019 Sep;43(9):2245-2249. doi: 10.1007/s00268-019-05022-x. World J Surg. 2019. PMID: 31098669
-
Peripherally inserted central venous catheters are not superior to central venous catheters in the acute care of surgical patients on the ward.World J Surg. 2006 Aug;30(8):1605-19. doi: 10.1007/s00268-005-0174-y. World J Surg. 2006. PMID: 16865322 Review.
-
Imaging of the complications of peripherally inserted central venous catheters.Clin Radiol. 2009 Aug;64(8):832-40. doi: 10.1016/j.crad.2009.02.021. Epub 2009 Jun 16. Clin Radiol. 2009. PMID: 19589422 Review.
References
-
- Chen X-P, Jian-Ping WANG. Ji-zong. The ninth edition. Beijing: People’s Medical Publishing House; 2018. pp. 770–9.
-
- Xu Hairong N, Xiaohui L, Yuan, et al. Clinical analysis of 9200 primary malignant bone tumors in Beijing jishuitan hospital. Chin J orthopaedic clinic & research. 2016;1(1):51–4. doi: 10.3969/j.issn.2096-269X.2016.01.010. - DOI
-
- Paolo DTA, Fleur W, Abbas A et al. Datasets for reporting of the Soft Tissue Sarcoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). HISTOPATHOLOGY. 2023. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical